Key result
A 55-year-old man with recurrent primary pulmonary malignant fibrous histiocytoma was successfully treated with doxorubicin-based chemotherapy and radiotherapy, remaining disease-free for 36 months.
Case Report (n=1)
No
This case report demonstrates the potential for long-term recurrence-free survival using chemotherapy and radiotherapy for recurrent primary pulmonary malignant fibrous histiocytoma.
May support doxorubicin-based chemoradiotherapy for recurrent primary pulmonary malignant fibrous histiocytoma; leaves open need for prospective validation.
We describe herein an extremely rare case of a recurrent primary pulmonary malignant fibrous histiocytoma 3 months after operation that occurred in a 55-year-old man who was treated with chemotherapy and radiotherapy successfully. Until now, 36 months later, the patient has shown no evidence of tumor recurrence. The clinical, radiographic, and pathologic features are reported here together with a brief review of the literature.
No takes yet. Share an insight, caveat, or question.
Jeon et al. (2012) conducted a case report in Recurrent primary malignant fibrous histiocytoma of the lung (n=1). Chemotherapy (doxorubicin) and radiotherapy was evaluated on Tumor recurrence. A 55-year-old man with recurrent primary pulmonary malignant fibrous histiocytoma was successfully treated with doxorubicin-based chemotherapy and radiotherapy, remaining disease-free for 36 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: